You can buy or sell ArQule and other stocks, options, ETFs, and crypto commission-free!
ArQule, Inc. Common Stock, also called ArQule, is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. Read More The company discovers, develops and commercializes novel small molecule drugs in areas of unmet need that will dramatically extend and improve the lives of its patients. Its proprietary pipeline includes ARQ 531, Derazantinib, Miransertib, ARQ 751 and Derazantinib products. The company was founded in 1993 and is headquartered in Burlington, MA.
52 Week High
52 Week Low
Research And Development
Expected Aug 1, Pre-Market